Hypogonadism

Latest News

Testosterone for Hypogonadism Not Associated With Short- to Medium-Term CV Risk

By

Jessica Nye, PhD

A study was conducted to determine the cardiovascular safety of testosterone therapy for treatment of hypogonadism.

Testosterone Levels Increase for Obese Teen Males After Bariatric Surgery

For adolescent males with severe obesity, bariatric surgery is associated with an increase in testosterone concentrations.

Regular Exercise and Sex Hormone Concentrations in Older Men

By

Maria Arini Lopez, PT, DPT, CSCS, CMTPT

Researchers explored the association between circulating sex hormones, motor unit characteristics, and exercise in older men, including master athletes.

COVID-19 Is Associated With Low Testosterone in Men

By

Jody A. Charnow

Study reveals that almost 90% of men have hypogonadism at the time of hospital admission for COVID-19.

Poor Clinical Outcomes From COVID-19 Among Men Linked to Lower Testosterone

By

Jessica Nye, PhD

Study finds increased risk for severe disease and mortality among men hospitalized with COVID-19 and low testosterone and high estradiol-to-testosterone ratio.

Short-Acting Testosterone Replacement Therapy Better for Spermatogenesis

By

Endocrinology Advisor Contributing Writer

Study authors hypothesized that longer-acting testosterone replacement therapy will have significant impact on suppressing HPG axis compared with short-acting TRT preparations.

Treatment With Testosterone Significantly Reduces T2D Risk

By

Brandon May

Overweight or obese men frequently have low serum testosterone concentrations, which is associated with increased risk of type 2 diabetes.

Nasal Gel Increases Testosterone, Maintains Semen Parameters

By

Jody A. Charnow

In a study, most symptomatic hypogonadal men treated with Natesto, a short-acting 4.5% nasal testosterone gel, attained normal testosterone levels at 6 months while preserving sperm counts.

First Testosterone Undecanoate Softgel Approved by FDA for Hypogonadism

By

Steve Duffy

Jatenzo® (testosterone undecanoate; Clarus Therapeutics), an oral testosterone replacement therapy, is now available for the treatment of hypogonadism.

ACP Issues Guidelines for Use of Testosterone Therapy in Age-Related Low Testosterone

By

Rachael Beairsto

The American College of Physicians has issued a set of recommendations to clarify the potential benefits and harms of testosterone therapy in men with age-related low testosterone.

Waist Circumference Affects Coronary Plaque Accumulation in Testosterone Therapy

By

Amit Akirov, MD

Older men receiving testosterone treatment with higher waist-to-hip ratio experience greater increases in noncalcified coronary plaque volume.